MedPath

Aeye Health, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images

Not Applicable
Completed
Conditions
Diabetic Retinopathy, DR
Diabetic Mellitus
First Posted Date
2024-02-05
Last Posted Date
2025-03-18
Lead Sponsor
AEYE Health Inc
Target Recruit Count
601
Registration Number
NCT06241664
Locations
🇺🇸

Clinical Trial Network, Houston, Texas, United States

Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images

Not Applicable
Completed
Conditions
Diabetic Retinopathy
Diabetes Mellitus
First Posted Date
2023-05-15
Last Posted Date
2023-11-08
Lead Sponsor
AEYE Health Inc
Target Recruit Count
363
Registration Number
NCT05857943
Locations
🇺🇸

Karas Health Care, Fayetteville, Arkansas, United States

🇺🇸

Lake Nona Research, Orlando, Florida, United States

🇺🇸

The Jackson Clinic, Jackson, Tennessee, United States

Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images

Not Applicable
Completed
Conditions
Diabetes Mellitus
Diabetic Retinopathy
First Posted Date
2020-11-03
Last Posted Date
2023-08-01
Lead Sponsor
AEYE Health Inc
Target Recruit Count
531
Registration Number
NCT04612868
Locations
🇺🇸

The Eye Care Institute, Louisville, Kentucky, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath